Shinobu Shimizu

7PUBLICATIONS
30CO-AUTHORS
NeonatologyChiropracticNaturopathyMajor global burdens of diseaseRehabilitation engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 05, 2026
Intravenously delivered multilineage-differentiating stress-enduring cells dampen hyperoxia-induced lung injury in a rat model with features of bronchopulmonary dysplasia.

|Jan 24, 2026
Novel stem cell therapy for cerebral palsy using stem cells from human exfoliated deciduous teeth.

Takahiro Kanzawa, Atsuto Onoda, Azusa Okamoto

|Mar 18, 2025
Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocol.

Shinobu Shimizu, Akihito Tanaka, Nao Matsuyama

|Apr 27, 2022
Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial.

Nao Matsuyama, Shinobu Shimizu, Kazuto Ueda

|Feb 26, 2022
Influence of background characteristics in responders of regenerative therapy by periurethral injection of adipose-derived regenerative cells for male stress urinary incontinence.

Tomonori Yamanishi, Osamu Ishizuka, Shinobu Shimizu

|Nov 23, 2020
Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy.

Toshihiko Suzuki, Yoshiaki Sato, Yoshihiro Kushida

Pageof 2

Frequent Collaborators

4 joint publications

Toshihiko Suzuki

3 joint publications

Yoshiaki Sato

3 joint publications

Sakiko Suzuki

1 joint publications

Atsuto Onoda